Knowledge Center

Patent / Jun 29, 2017

Tetracycline topical formulations, preparation and uses thereof in treating an ocular condition

Authors:
  • Mohammad Salman
  • Arturo Angel
  • Vijaya Swaminathan
  • George Magrath
Source:
US 20170182071 A1 20170629

The invention relates to a topical suspension formulation that includes a tetracycline, a liq. medium and a polymeric gelling agent. The tetracycline may be in the form of its pharmaceutically acceptable salts, hydrates, or polymorphs and is in a suspended form within the formulation. The liq. medium is selected such that it does not dissolve or substantially minimally dissolves the tetracycline. The gelling agent is a polymeric hydrocarbon gelling agent. Preferably, the tetracycline has a particle size of less than or equal to about 20 μ.

Also in the Knowledge Center

Related Content

Spray drying

Spray drying has become one of the most successful particle engineering technologies for improving drug bioavailability through the amorphous solid dispersion platform.

Page
Read more

Potent compounds

Safety first

Page
Read more

Global Sales and Marketing Meeting - GSM 2023

Hi there! Find here the relevant information about the Global Sales, Marketing & Communications and PMO Meeting in Lisbon, Portugal.

Page
Read more